Valued at USD 1.8 billion in 2024, the global oral proteins and peptides market is expected to expand at a CAGR of 7.13% between 2025 and 2033, reaching USD 3.4 billion by 2033, as per IMARC Group. North America led the market with a staggering share of 97.8% in 2024. Key growth drivers include advanced drug delivery technologies, surging demand for non-invasive therapies, and the inc... https://www.imarcgroup.com/oral-proteins-peptides-market